Doxorubicin immunoassay

Details Doxorubicin immunoassay Doxorubicin immunoassay

2006-03-27

2009-08-04

Haq, Shafiqul (Department: 1641)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving antigen-antibody binding, specific binding protein...

C435S007100, C436S518000, C436S523000, C530S402000, C530S403000, C530S389800, C530S807000

Reexamination Certificate

active

07569358

ABSTRACT:
Novel conjugates of doxorubicin and novel doxorubicin immunogens derived from the 13 and 14 positions of doxorubicin and antibodies generated by these doxorubicin linked immunogens all of which are useful in immunoassays for the quantification and monitoring of doxorubicin in biological fluids.

REFERENCES:
patent: 4990443 (1991-02-01), Huber et al.
patent: 5122368 (1992-06-01), Greenfield et al.
patent: 5177016 (1993-01-01), Balsari et al.
patent: 5824805 (1998-10-01), King et al.
patent: 6146658 (2000-11-01), Bosslet et al.
patent: 2006/0172356 (2006-08-01), Ouyang et al.
patent: 0316776 (1989-05-01), None
patent: 554708 (1993-08-01), None
Noli et al. Antibodies against the antibiotics: and overview. Ann. 1st. Super Sanita 1991, vol. 27, No. 1, pp. 149-154.
International Search Report dated Aug. 21, 2006.
Written Report dated Aug. 21, 2006.
King, et al. Monoclonal antibody conjugates of doxorubicin prepared with pepticide linkers: Inhibition of aggregation by methoxytriethyleneglycol chains. J. Med. Chem. 2002, vol. 45, pp. 4336-4343, especially scheme I of p. 4337.
King, et al. Monoclonal antibody conjugates of doxorubicin prepared with branched linkers; a novel method for increasing the potentcy of doxorubicin immunoconjugates. Bioconjugate Chem. 1999, vol. 10, pp. 279-288, expecially scheme I of p. 280.
Vunakis, et al., Radioimmunoassays for Adriamycin and Daunomycin, Cancer Research. Oct. 1974; 34 (10):2546-52.
Fujiwara, et al., Novel preparation method of immunogen for hydrophobic hapten, enzyme immunoassay for daunomycin and adriamycin, Journal of Immunol Methods, 1981;45(2): 195-203.
Hirano, et al., Determination of Adriamycin by Enzyme Immunoassay, Journal of Pharmacobiodyn. Aug. 1983; 6(8):588-594.
Watanabe, et al., Measurement of Cross-Reactive Properties of Adriamycin Derivatives by the Inhibition Enzyme-Linked Immunosorbent Assay for Adriamycin, The Tokai journal of experimental and clinical medicine, Jul. 1990 15(4):327-334.
Watanabe, et al., Production and Properties of Mouse Monoclonal Anti-Adriamycin Antibody, The Tokai journal of experimental and clinical medicine, Dec. 1994 19(3-6): 103-107.
Balsari, et al., Monoclonal Antibodies Against Doxorubicin, Int. J. Cancer: 42, 798-802 (1988).
Balsari, et al., A New Monoclonal Antibody Recognizing Anthracyclinic Molecule, Anticancer Research 10: 129-132 (1990).
Verdina et al., Search of Anti-Adriamycin Antibodies in Serum of Cancer Patients under Chemotherapic Theatment, J. Exp. Clin. Cancer Res., 21, 3, 2002.
Citro, et al., Quantitation of Adriamycin Content by a Sensitive Immunochemical Assay, Anticancer Research 8, 549-552 (1988).
Reddy et al., Production of hybrids secreting bispecific antibodies recognizing CEA and Doxorubicin, Anticancer Research 1993, 13:2077-2084.
Fujiwara, et al., Immunocytochemistry for drugs containing an aliphatic primary amino group in the molecule, anticancer antibiotic daunomycin as a model, Journal of Histochem & Cytochem, Apr. 2005;53.
Danesi et al., Pharmacokinetic-Pharmacodynamic Relationships of the Anthracycline Anticancer Drugs, Clinical Pharmacokinetics, vol. 41, No. 6, 2002, pp. 431-444(14).

Affiliated with

Also associated with

Rating

Doxorubicin immunoassay does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Doxorubicin immunoassay, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Doxorubicin immunoassay will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4095717